ResearcherShaanxi Provincial People's HospitalNo recent work listed

Baojun Duan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8375-7951; OpenAlex author ID A5058138784. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma. Co-author DOI 10.4251/wjgo.v14.i7.1252 ↗
RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer. Co-author DOI 10.1002/prca.201900048 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xi Wang · 1 shared paper, 2022 · strength 0.12
- Paper Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma. DOI 10.4251/wjgo.v14.i7.1252 ↗
Yuan Hu · 1 shared paper, 2022 · strength 0.12
- Paper Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma. DOI 10.4251/wjgo.v14.i7.1252 ↗
Enxiao Li · 1 shared paper, 2022 · strength 0.12
- Paper Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma. DOI 10.4251/wjgo.v14.i7.1252 ↗
Zheng Wang · 1 shared paper, 2019 · strength 0.09
- Paper RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer. DOI 10.1002/prca.201900048 ↗
Chen Yu Huang · 1 shared paper, 2019 · strength 0.09
- Paper RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer. DOI 10.1002/prca.201900048 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.